Holen Sie sich die Stockscreener-App
1.40
14.75%
0.18
Vorhandelsmarkt:
1.40
Schlusskurs vom Vortag:
$1.22
Offen:
$1.23
24-Stunden-Volumen:
1.06M
Relative Volume:
4.87
Marktkapitalisierung:
$115.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.65M
KGV:
-4.2156
EPS:
-0.3321
Netto-Cashflow:
$-15.84M
1W Leistung:
+8.53%
1M Leistung:
+12.90%
6M Leistung:
+6.06%
1J Leistung:
-36.94%
1-Tages-Spanne:
$1.23
$1.44
1-Wochen-Bereich:
$1.14
$1.44
52-Wochen-Spanne:
$0.7709
$2.63
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Vergleichen Sie CRDL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.40 | 106.62M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-06-26 | Eingeleitet | ROTH MKM | Buy |
| 2024-04-22 | Eingeleitet | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten
What drives Cardiol Therapeutics Inc. stock priceHigh-return market picks - jammulinksnews.com
What analysts say about Cardiol Therapeutics Inc. stockExtraordinary profit generation - jammulinksnews.com
Cardiol rises on database lockup for acute myocarditis therapy trial - Seeking Alpha
Cardiol To Report ARCHER Study Data Within The Next Two Weeks - Nasdaq
Is Cardiol Therapeutics Inc. a good long term investmentTriple-digit profit margins - jammulinksnews.com
Cardiol Therapeutics Achieves Database Lock in ARCHER Trial for Acute Myocarditis - TipRanks
Cardiol Therapeutics announces database lock for myocarditis trial - Investing.com Australia
Cardiol Therapeutics Announces Database Lock for Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Stock Titan
Cardiol Therapeutics Inc. Stock Analysis and ForecastFastest-growing stock picks - jammulinksnews.com
(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Investment Analysis (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (NASDAQ:CRDL) Shares Down 8.5% – Here’s What Happened - Defense World
Cardiol Therapeutics shares rise 3.88% premarket after CMS achieves secondary listing on Singapore Exchange. - AInvest
Why Cardiol Therapeutics Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser
How Cardiol Therapeutics Inc. stock performs during market volatilityFree Short-Term Stock Picks - Newser
What makes Cardiol Therapeutics Inc. stock price move sharplyBreakout Momentum Alerts - Newser
(CRDL) On The My Stocks Page (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Stock Market Analysis (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (OTCMKTS:CRTPF) Trading Up 10.8% – Still a Buy? - Defense World
Cardiol Therapeutics (TSE:CRDL) Trading Up 1% – Here’s Why - Defense World
(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Technical Patterns and Signals (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (TSE:CRDL) Trading Up 2.1% – Here’s What Happened - Defense World
(CRDL) Financial Trading Report (CRDL:CA) - news.stocktradersdaily.com
Analysts Issue Forecasts for CRDL Q2 Earnings - Defense World
All Eyes On ARCHER: Will Cardiol's Drug For Heart Muscle Inflammation Hit The Mark? - RTTNews
Cetera Investment Advisers Takes $56,000 Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World
Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World
This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
HC Wainwright & Co. Initiates Coverage of Cardiol Therapeutics (CRDL) with Buy Recommendation - Nasdaq
Cardiol Therapeutics (CRDL): HC Wainwright & Co. Initiates Coverage with a Buy Rating and $9 Price Target | CRDL Stock News - GuruFocus
H.C. Wainwright Initiates Coverage on Cardiol Therapeutics (CRDL) With Positive Outlook | CRDL Stock News - GuruFocus
(CRDL) Strategic Investment Guide (CRDL:CA) - news.stocktradersdaily.com
Finanzdaten der Cardiol Therapeutics Inc-Aktie (CRDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):